Markets.com Logo
markets.com

NEIMETH

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    --
  • Previous Close
    --
  • 52 Week Change
    --
  • Day Range
    --
  • 52 Week High/Low
    --
  • Dividend Per Share
    --
  • Market cap
    --
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

NEIMETH.XNSA represents the shares of Neimeth International Pharmaceuticals Plc, a pharmaceutical manufacturing company listed on the Nigerian Exchange Limited (NGX). The company focuses on the production, marketing, and distribution of a range of pharmaceutical products including antibiotics, analgesics, and hematinics, serving both the human and animal health markets in Nigeria and beyond. Investment in NEIMETH.XNSA provides exposure to the Nigerian pharmaceutical sector and the potential growth of a company with a long-standing presence in the local market.
markets.com
Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Julian Parker|--
AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

Daniel Carter|--
AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

Julian Parker|--
British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

Julian Parker|--
Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Daniel Carter|--

The energy sector remains a hot topic & precious metals

Darius Anucauskas|--
Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Julian Parker|--

Factors

NEIMETH.XNSA Stock Price Factors Company Performance: Revenue, profits, and growth rates directly influence investor confidence. Strong financial results typically drive prices up; weak results often cause them to decline. Industry Trends: Overall performance of the pharmaceutical sector and specific market segments (e.g., generics, oncology) that NEIMETH.XNSA participates in affects investor sentiment and stock valuation. Regulatory Environment: Changes in drug approval processes, pricing regulations, and healthcare policies can significantly impact NEIMETH.XNSA's future earnings and, consequently, its stock price. Economic Conditions: Macroeconomic factors such as inflation, interest rates, and overall economic growth influence investor risk appetite and the attractiveness of NEIMETH.XNSA stock relative to other investments. Market Sentiment: General investor mood, often driven by news events, can create short-term price fluctuations that may not be directly related to NEIMETH.XNSA's fundamentals.

People Also Watch

Latest news

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Julian Parker|--
McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

Julian Parker|--
Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

Julian Parker|--

Latest Education Articles

Risk Management 101

Risk Management 101

Julian Parker|--
Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Julian Parker|--
Gold Scalping Strategy: How Scalping XAU/USD Works

Gold Scalping Strategy: How Scalping XAU/USD Works

Julian Parker|--
Recommended Topics
markets.com